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ABSTRACT
It is estimated that 1 in 10 hospital inpatients in Scotland 
have experienced a medication error. In our unit, an 
audit in 2019 identified documentation of as- required 
prescriptions on drug Kardexes as an important target for 
improvement. This project aimed to reduce the percentage 
of these errors to <5% in the ward in 6 months.
Weekly point prevalence surveys were used to measure 
medication error rates over a 12- week baseline period. 
Errors in route, frequency of dose and maximum dose 
accounted for >80% of all prescribing errors. The 
intervention was a poster reminder about the three most 
common errors linked to standards for prescribing pain 
medication. Barriers to change were identified through 
inductive thematic analysis of semistructured interviews 
with five ward doctors and two staff nurses.
In the 6 weeks after intervention, our run chart showed 
a shift in maximum dose errors per patient, which fell 
from 75% to 26%. However, route and frequency errors 
remained high at >70% per patient. Most of these 
errors were due to use of abbreviations, and qualitative 
interviews revealed that senior doctors and nurses 
believed that these abbreviations were safe. We found 
some evidence from national guidelines to support these 
beliefs.
Overall, the intervention was associated with decreased 
prevalence of patients without a maximum dose written on 
their prescription, but lack of space on drug prescriptions 
was identified as a key barrier to further improvement in 
both maximum dose and abbreviation errors.
PROBLEM
Inaccurate prescription documentation has 
the capacity to cause severe patient harm. 
A ward underwent audit of its patients’ 
Kardexes in mid-2019 to assess the scale of 
this problem, with feedback of results to the 
clinical team. Despite the existence of health 
board- wide prescribing guidelines in NHS 
Tayside,1 as- required or pro- re- nata (PRN) 
medications were found to be the poorest 
prescribed drugs, with accuracy between 20% 
and 40%. This was identified as an important 
target for improvement.
The ward is a 16- bed unit consisting of elec-
tive surgical patients, patients with cancer 
and emergency admissions with different 
prescribing demands. These patients often 
require pain medication and other as- re-
quired drugs such as antiemetics. The ward’s 3 
monthly rotational intake of foundation year 
1 (FY1) doctors was thought by the project 
team to have compounded the problem of 
inaccurate as- required prescribing as most 
prescribing in the ward is completed by 
doctors of this level. This project aimed to 
reduce the percentage of documentation 
errors of as- required medications in the ward 
within the 6- month intervention period.
BACKGROUND
Most prescriptions in UK hospitals are written 
by doctors in their first two FY of training. Two 
large UK studies reported errors in 7.4%–
8.4% of prescriptions written by FY doctors. 
Most patients in hospitals have more than one 
prescription, and consequently the prescrip-
tion error rate per patient was 32%–50%.2 3 
The most common suggested causes for these 
errors were in the work environment such as 
workload, interruptions, pressure from staff, 
cross- cover between wards and low staffing. 
Amongst individual factors, tiredness and 
stress were more frequent than insufficient 
knowledge or prescribing skills.2 Doctors 
have been found to adjust their performance 
to combat day- to- day challenges such as lack 
of time in the interest of patient safety; use of 
abbreviations would be an example of this.4 
Areas of as- required prescribing that were 
commonly missed in studies on prescription 
documentation were ‘indication of drug’ and 
‘frequency of dose’.5 6 These are examples of 
how doctors may skip what they deem as ‘less 
essential’ components of a prescription in the 
interest of saving time.
Prescribing is a four- step series of tasks: 
prescribing, transcribing, dispensing and 
administration.6 Each of these steps involves 
its own risks; however, evidence suggests that 
most errors occur in the ‘prescribing’ and 
‘administration’ phases.6–8 A medication error 
is generally defined as an error occurring in 
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occurs solely in the ‘prescribing’ phase.9 Prescribing can 
be further specified into regular medications (drugs the 
patient takes every day) and as- required medications (for 
symptomatic relief). Although as- required prescriptions 
are most commonly for pain, other common indications 
for this are nausea and vomiting, anxiety and allergies.10 
A systematic review identified very little evidence about 
the safety or effectiveness of as- required prescriptions 
in comparison with regular prescriptions and suggested 
that PRN safety issues and adverse events are under- 
recognised.7 10 PRN medications require more written 
information than regular medications, creating more 
opportunities for error. The prescriber must include the 
indication for the drug, its frequency and its maximum 
dose in 24 hours. If these steps are not completed, the 
drug may be administered incorrectly, resulting in serious 
harm to the patient. Despite this, literature is scarce on 
how to improve PRN prescribing.11 12 Some work has 
been done into evaluating the efficacy of PRN prescribing 
in psychiatric units; however, there is limited evidence of 
audit into how well these medicines are prescribed for 
indications such as pain and nausea, which form the bulk 
of PRN prescriptions on our ward.13
MEASUREMENT
Quantitative methods
Initial data collection using a point prevalence survey 
(PPS) took place in the ward over a period of 8 weeks to 
quantify the number of errors in the as- required section of 
each patient’s Kardex. An average of seven Kardexes were 
assessed each week using a structured template (online 
supplemental material 1). Errors were classified using 
NHS Tayside prescribing guidelines. This guideline does 
not include a full list of accepted abbreviations; however, 
it does include strict guidelines on how to document the 
route of administration appropriately and rejects ‘PO’ 
as an appropriate abbreviation for ‘oral’ (online supple-
mental material 2). The guideline also specifically states 
that ‘Latin or other abbreviations must not be used’ and 
that the frequency of dose must be written in full. Further-
more, the guideline recommends that for as- required 
medicines, the prescriber ‘must state the indication and 
give a clear statement of dose, maximum frequency, and 
the maximum dose to be administered in each 24- hour 
period’.1
The selected error domains based on these guidelines 
were no maximum dose included, improperly or omitted 
route of drug, improperly written or omitted indication 
of drug, improperly written or omitted frequency of dose, 
improperly written or omitted units of dose and ‘other’, 
which comprised any documentation error outside of the 
set domains.1
A primary outcome measure and a process measure 
were calculated from our PPS data:
Primary outcome measure: Percentage of patients on the 
ward with an as- required drug entry error.
Process measure: Number of as- required drug entry 
errors.
Of the Kardexes assessed at baseline for our primary 
outcome measure, a median of 50% of patients had an 
as- required prescription with an error. The most common 
errors were in the domains of route, frequency and 
maximum dose. The most common causes of these errors 
were omission of maximum dose or use of unsuitable 
abbreviations. The most common unsuitable abbrevia-
tions used were ‘PO’ instead of ‘oral’ when documenting 
drug route and a degree sign (°) written in place of 
‘hourly’ when noting frequency. Pareto chart analysis of 
our process measure results in the preintervention period 
showed that over 80% of errors occurred in these three 
domains (figure 1).
We utilised the 80:20 rule when conducting our Pareto 
chart analysis, which states that about 80% of effects come 
from 20% of the causes.14 15 According to the chart, route, 
frequency and maximum dose errors were what contrib-
uted the most to the total number of PRN prescribing 
errors on the ward.
The intended outcome of the intervention was a reduc-
tion in adverse drug events, which was our intended 
process measure. This was emphasised in the poster state-
ment ‘don’t put your patients at risk’ (online supplemental 
material 3). However, we could not measure adverse drug 
events for two reasons. First, they are uncommon; harm to 
patients occurs in <1% of undetected prescribing errors 
in hospitals.16 Consequently, large studies are required 
to detect the impact of medication safety interventions 
on patient outcomes.17 Second, the only available infor-
mation about adverse drug events was the hospital’s 
system for reporting patient safety incidents. However, a 
study of 1006 admissions to an NHS hospital in England 
found that only 33 (11%) of 303 adverse events identified 
through case note review were reported on the hospital’s 
reporting system.18
Figure 1 Pareto chart of number of as- required drug entry 
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We used qualitative methods to provide a balanced 
account of beliefs and attitudes about the intervention.19 
We did not include quantitative balancing measures.
Qualitative methods
Qualitative semistructured interviews were conducted 
with five doctors and two nurses with informed consent. 
Interviews lasted approximately 20–30 min and were 
audio- recorded to allow for verbatim transcription. They 
took place in staff offices (n=3) and the ward’s family 
room (n=4) to ensure confidentiality for our participants. 
Interviewees were not provided with any information or 
sources about the topic prior to the interview.
Interviews used specific topic guides for doctors 
(online supplemental material 4) and nurses (online 
supplemental material 5) to ensure all key questions were 
covered while keeping the interview open to new ideas. 
The questions asked in the interview focused on confi-
dence in writing (for prescribers) or reviewing (nurses) 
as- required prescriptions. This was because staff avail-
ability issues meant that some interviews (n=3) could 
not be undertaken in the postintervention period. As a 
result, our qualitative findings focused less on the effect 
of our intervention and more on staff opinions of PRN 
prescribing and its capacity for errors. Interview tran-
scripts were uploaded to NVivo V.12, and data manage-
ment, coding and initial analysis were conducted using 
this software. Inductive approaches were used throughout 
the thematic analysis of the transcript to allow the inter-
viewees’ themes to arise from their own discussions.
DESIGN
A small quality improvement (QI) team consisting of a 
medical student (SR) and a consultant (YB) was formed. 
Patients were not involved in the design, conduct, 
reporting or dissemination plans of our research as this 
was not feasible given the time frame for the project. 
Environmental factors for inaccurate PRN prescribing 
were identified through creation of a cause- and- effect 
diagram (see online supplemental material 6) using find-
ings from two ward observation sessions conducted by 
the project lead (SR). These were applied to the COM- B 
Model of Behaviour to identify target barrier behaviours 
for a behavioural diagnosis.20 From our analysis of the 
model (online supplemental material 7), ‘opportunity’ 
was found to be the dominant COM- B component in 
which barrier behaviours to accurate PRN prescribing 
were driven, with ‘physical opportunity’ in the context of 
the ward environment emerging as the dominant barrier 
behaviour. This information was then applied to Michie’s 
Behaviour Change Wheel.20 We identified three poten-
tial intervention functions—persuasion, incentivisation 
and coercion—through the means of either environ-
mental or social planning, communication, marketing 
or legislation. The busy nature of the ward meant that 
junior doctors required a quick and effective tool to help 
them with PRN prescriptions. A poster intervention was 
selected as the team felt it was a good combination of 
each intervention function and was manageable given the 
time frame for the project. Most prescribing took place 
in the ward’s doctors’ room; therefore, a poster in this 
location was most suitable for our target population to 
maximise ease of access.
Our poster was developed using NHS Tayside’s 
prescribing ‘pain ladder’ guideline, which contains 
our health board’s recommended pain medication for 
patients across all specialties who have mild, moderate 
or severe pain.21 The poster also focused on prevention 
of errors in the three main error domains identified 
from our baseline data collection (online supplemental 
material 3). The poster was laminated and put up in the 
doctors’ room as well as other key areas where prescribing 
tasks were known to take place.
Data collection was reinitiated after the introduction of 
the poster and was conducted in the same fashion as the 
preintervention data to assess for improvement in as- re-
quired prescribing. Plan- do- study- act (PDSA) cycles were 
used to monitor the intervention and provide modifica-
tions where appropriate (online supplemental material 
8).
STRATEGY
Our SMART aim was to decrease as- required documen-
tation errors on drug Kardexes to <5% by April 2020. We 
used a set of PDSA cycles to monitor and adapt our inter-
vention design to ensure our method was suitable for the 
ward environment.
Our data collection method was a weekly PPS using 
a template (online supplemental material 1) to gain a 
‘snapshot’ of patient Kardexes at a set time each week. 
It was predicted that collecting data in this way would 
give the team an understanding of the rate at which PRN 
prescribing errors occurred on the ward.
PDSA cycles
A poster was introduced to the ward to remind doctors of 
best practice when prescribing as- required medications. 
The project team wanted to maximise the potential of the 
intervention through PDSA cycles. These represent plan-
ning (PDSA 1.1) and design (PDSA 1.2) of the poster and 
redevelopment of the poster using cues from the internal 
environment and staff behaviours (PDSA 1.3).
PDSA cycle 1.1 (October 2020): The team planned 
to use up- to- date pain guidelines to form the content of 
our poster. We searched various guidelines to create the 
template; however, no updated material was available. 
The team thought this was because the content was being 
accessed via a personal computer instead of an NHS 
computer. We accessed an NHS computer with Staffnet 
to print out the most recent pain ladder guidelines for 
Tayside; this was then used as a template to create a pain 
ladder poster.21
PDSA cycle 1.2 (November 2020): An A4 poster was 
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Ward prescribers and reviewers were informed about 
the poster and its purpose to ensure staff knew where to 
seek help if they needed it. One week after the poster was 
introduced to the noticeboard, it had been moved by a 
member of staff behind other guidelines on the wall. A 
new location was sought to prevent staff tampering with 
the poster.
PDSA cycle 1.3 (November–December 2020): The 
poster was laminated to increase its durability and had 
bolder colours to attract the eye of FY1s working at their 
station. More posters were printed out and added to other 
areas of the ward where prescribing was known to take 
place, such as the dispensing room and the nurses’ tables 
at the end of each bed bay. Staff were informed of the 
new locations of the posters. One week later, there was 
no further movement of the posters. These locations trig-
gered a slight improvement in PRN prescribing as after 
intervention there was a 39.2% decrease in the number 
of prescribing errors on patients’ Kardexes.




From the quantitative baseline data, the two most 
common error domains were that of ‘frequency’ and 
‘route’ because of the use of abbreviations (figure 1). The 
most common term used to abbreviate the frequency of 
dose was a degree (°) sign in place of writing out ‘hourly’ 
in full, and the most common abbreviation found in the 
‘route’ domain of the Kardex was ‘PO’ in place of writing 
out ‘oral’. These were the most common prescribing 
errors seen throughout the entire data collection process. 
Staff opinions were investigated using semistructured 
qualitative interviews with ward staff to discover whether 
they thought using abbreviations on drug Kardexes was 
appropriate.
In summary, interviewees used abbreviations in the 
Kardex for three main reasons: common knowledge, 
habit and because of physical barriers such as lack of 
space to write a full prescription. Although physical 
barriers and habit were justifiable reasons for abbrevi-
ating prescriptions from the data, there were discrepan-
cies between the doctors’ and nurses’ opinions on how 
easily their prescriptions were interpreted by nursing staff, 
with illegibility being a key issue for Staff Nurse A. Inter-
view data provided significant evidence that there was an 
abbreviations- supportive culture on the ward resulting 
from these contributing factors. This provided the team 
with insight as to why the quantitative errors detected 
were most often from abbreviations of drug route and 
frequency. Qualitative interviews also provided us with 
information on why maximum dose was often missed out 
by prescribers; this was because it involves a lot of writing 
in a small space. Hierarchical themes from the interviews 
are summarised in online supplemental material 9.
Quantitative results
Results for our outcome measure data preintervention 
and postintervention were expressed in the form of 
run charts for each error domain: route, frequency and 
maximum dose. Results were collated into preinterven-
tion weeks (1–7) and postintervention weeks (1–8). Data 
for preintervention week 1 were not formally recorded 
as pilot data collection took place at this time. Data for 
maximum dose errors were not recorded until preinter-
vention week 4 because this information was not originally 
included as one of the error domains in our template. A 
‘maximum dose’ error domain was added after the team 
found poor compliance with maximum dose documenta-
tion in the first 3 weeks of data collection (online supple-
mental material 1).
Run charts showed that the intervention was not asso-
ciated with any change in the frequency of errors in the 
domains of route (figure 2A) or frequency (figure 2B). 
The run chart for maximum dose errors (figure 2C) 
did show some improvement after the poster was intro-
duced. A shift (circled) can be seen on the run chart from 
weeks 3 to 8 after intervention, with 7 points below the 
median. This indicates there was a non- random change 
to the prescribing process during this time. No trends or 
astronomical data points were present. Error rates over 
both the preintervention and postintervention period are 
summarised in online supplemental material 10.
LESSONS AND LIMITATIONS
The main lesson learnt from this project was that 
prescribing is a multifaceted task that is the responsi-
bility of not only the prescriber but also reviewers such as 
nursing staff and pharmacists. Kardexes were reviewed by 
nurses two times per day and less frequently by pharma-
cists. At the time of data collection, there was no set ward 
pharmacist. Lack of support during the review process 
may have contributed to why errors were not being picked 
up or communicated to doctors effectively at the time.
Abbreviations were the most common error and were 
unaffected by our poster intervention. Lessons were 
learnt from the interviews about likely causes. Both 
consultants said they would use abbreviations regularly 
(table 1). In contrast, two of the three junior doctors inter-
viewed showed awareness that they were not supposed 
to abbreviate prescriptions. Importantly, both nurses 
were content with doctors using abbreviations if hand-
writing was legible. A previous qualitative study with 22 FY 
doctors found that senior doctors were seen to be highly 
influential to their prescribing behaviour through both 
informational (the influence of other people’s knowl-
edge and skills on our behaviour) and normative (the 
influence of what other people expect one to do) path-
ways. These interviews also revealed a common belief that 
prescribing errors are not likely to have consequences for 
patients.22 This led us to reflect on the evidence about 
consequences of the abbreviations that were common in 
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appear in the US Joint Commission’s official ‘Do Not Use’ 
list of abbreviations23 and is specifically included as safe 
in the Australian Commission on Safety and Quality in 
Healthcare’s national recommendations.24 The (°) abbre-
viation is not in the US ‘Do Not Use’ list, but the Austra-
lian recommendations say, ‘Do not use symbols. Avoid, 
for example, “°2” to mean “every 2 hours.”’ However, it is 
not in their list of high- risk abbreviations.24 An example 
of a high- risk abbreviation is ‘U’ for units. For example, 
prescription of 6iu (6 international units) has been inter-
preted as 61 units and prescription of 10U (10 units) has 
been interpreted as 100 units. In both cases, the patients 
were harmed; the first was admitted to hospital and the 
second transferred to intensive care.25 The lesson that we 
have learnt is that the abbreviations we identified are not 
high risk. Nonetheless, nursing staff find doctors’ hand-
writing hard to read, and abbreviations exacerbate this 
problem (table 1). The policy on abbreviations applies 
to all hospital units in NHS Tayside, and consequently 
changing the policy on a single ward is not an option.1
None of the interviewees questioned the need to 
specify a maximum dose, yet our poster intervention 
was associated with a reduction in maximum dose errors 
(figure 2C). However, reduction in these errors began 
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before the intervention, which may have been due to a 
Hawthorne effect; the need to prescribe maximum doses 
was discussed with staff in the first 3 weeks of data collec-
tion when its documentation in the Kardex was found to 
be infrequent.26 Despite improvement, the postinterven-
tion median for maximum dose errors was 22% (online 
supplemental material 10), which is well above the target 
of <5%. Interviewees identified lack of space on the 
Kardex as a major barrier to specifying maximum doses 
and eliminating abbreviations.
Only one person (SR) was responsible for all quanti-
tative and qualitative data collection and analysis, which 
may have introduced unintentional bias to the project. 
The investigator visited the ward every week and there-
fore got to know ward staff, of whom some were also 
participants in qualitative interviews. Interviewer bias 
was avoided, where possible; however, participants could 
have felt influenced to answer questions in a certain way 
because of the investigator’s role as a medical student.
The main limitation in this study lies in its generalis-
ability, as the project took place in a single hospital ward. 
As the sample size was low in terms of ward capacity 
(n=16), the findings from this study are unlikely to be 
generalisable to other areas. This weakens our project’s 
sustainability as it renders us unable to benefit from 
spreading our project beyond our local area through 
word- of- mouth (diffusion) or poster redistribution 
(dissemination); these are key elements of a sustainable 
QI project according to the diffusion and dissemination 
paradigm.27 28 As the ward contains a high volume of 
surgical patients, many Kardexes were with the patient 
in surgery at the time of data collection or were missing. 
This meant the sample size of Kardexes was low, with an 
average of seven available each week for audit.
Furthermore, other issues surrounding sustainability 
are important to consider as FY1s rotate every 4 months 
to a new area; the new cohorts would therefore have to 
be informed of the poster for it to be fully effective. As 
the lead researcher (SR) was a medical student based on 
the ward for 12 months, this was only possible for those 
who joined the ward during this period. Other team 
members were either not ward- based (PD and SG) or 
Table 1 Doctors’ and nurses’ attitudes to abbreviating prescriptions on a drug Kardex
Interviewee Stance on abbreviations Justification
Consultant A Would abbreviate a prescription Habit
‘I would be used to writing “IM” and “SC” and “PO”’
Consultant B Would abbreviate a prescription Common knowledge
‘… everybody knows what “PO” and “IV” mean’
Registrar Tries not to abbreviate Habit
‘I’m trying to stick to guidance as much as I can but it’s with any of these 
things, sometimes you’re so used to doing it a certain way’
FY1 A Tries not to abbreviate Lack of space on Kardex
‘I try and avoid things like “TDS” and “QDS” if possible because I think 
it’s easily misinterpreted so I try and avoid those. Again, sometimes space 
is an issue so even words like “maximum”; I’m going to cut that down to 
‘max’ because there’s no box in that Kardex that you can fit “maximum” 
into’.
FY1 B Would abbreviate a prescription Lack of space on Kardex
‘there’s no space to write that so I write ‘Four times a day’ and I know the 
nurses know what that means’
‘… I do use the 1 and a circle (°) for hourly and I know you’re not 
supposed to do that but sometimes it’s just not feasible’
Staff Nurse A Confidence with reading 
abbreviations depends on 
doctors’ handwriting quality
Depends on Handwriting
‘Most of them I know but sometimes it will be like—sometimes it depends 
on the doctor’s writing as well—it can look like something else as well, 
it can look like something else and you don’t know what it’s meant to 
say. Same with numbers and things as well, sometimes the way doctors 
write their numbers … it can look like a completely different number if you 
know what I mean’.
Staff Nurse B Is content with doctors using 
abbreviations
Experience
‘I mean, I use PO when I’m doing it. Yeah, IM and SC and everything, I’m 
fine with that. Again, maybe brand- new staff would need to have it written 
out a bit better but I’m certainly okay with it because I know what they all 
mean. But someone might not know what Three times a day or BD means 
which is automatic because the doctors always put that, they’re not going 
to put ‘twice a day’ or anything. I’m personally okay with it because I 
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were consultants (YB) who are only on the ward for a 
short space of time. This demonstrates how involvement 
from staff members working in the target environment is 
essential for the sustainability of an improvement project.
Our results show that a poster intervention alone is 
not sustainable or sufficient to improve all elements of 
prescribing on the ward. Around 70% of planned organ-
isational change fails, and this is most often a result of 
design flaws in the planning stage of a project.27 NHS 
Improvement divides this into three areas: staff, organisa-
tion and process.29 More effort should have been made to 
involve our target group in the design of our project; this 
could have been done by conducting interviews earlier 
in the year during our preintervention stage. Organisa-
tional factors such as availability of prescribing tools and 
staff training could have been evaluated in more detail. 
Furthermore, the process- related benefits to the system 
could also have been evaluated, for example, does accu-
rate prescribing make other parts of the system run more 
smoothly? More communication regarding the benefits 
of accurate PRN prescribing should have been made 
clear to patients, staff and the organisation to maximise 
sustainability.29
Our intervention was a simple, cost- effective method 
of eliciting improvement and was easy to distribute 
throughout the ward. However, this is a passive method 
of changing practitioner behaviour and did not bring 
PRN error rates down to our target of <5% by 6 months. 
A poster can also be easily moved or misplaced, which 
further impedes its efficacy, as PDSA cycle 1.2 demon-
strated. The use of passive interventions such as posters 
to prevent erroneous behaviours has been successful30 31; 
however, evidence shows it is more effective when done in 
combination with an active intervention.32 33 Qualitative 
interviews with ward staff were a strength of our project; 
by examining the contrasts and similarities between 
doctors and nurses on the ward, we had the opportunity 
to understand the views of our stakeholders. Solutions 
were also offered by interviewees such as providing more 
space to write in the Kardex. A key recommendation from 
this project is to involve the target population early to 
implement their views into the project design.
CONCLUSION
This study aimed to improve documentation accuracy 
of as- required prescriptions on hospital inpatients’ drug 
Kardexes. A poster intervention introduced to the ward 
was successful in reducing the ward’s rates of maximum 
dose documentation errors but had no impact on abbre-
viations. Our work shows that passive dissemination of 
posters has some capacity to enact change in prescribing 
behaviour; however, we acknowledge that further progress 
with reducing prescribing errors on our ward is likely to 
require redesign of the drug Kardex to allow for more 
space to write prescriptions in full. The next steps for this 
project involve taking on board the suggestions from our 
qualitative interviews to redesign a new Kardex for the 
ward to facilitate PRN prescribing.
Improving PRN prescribing involves a multisystem 
effort from doctors and nurses to encourage safe prac-
tice; however, outside pressures continue to impede this 
process.34 35 A supportive approach to safety is required 
in healthcare to provide prescribers with the opportunity 
to learn from their errors to both inform their own and 
others’ learning.4 In addition to this, review of local guid-
ance for abbreviations on prescriptions should be encour-
aged across all health boards
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                                                                   SUPPLEMENTARY MATERIAL 1: POINT PREVALENCE SURVEY (PPS) TEMPLATE 

















(please use generic drug 
name e.g paracetamol) 
Reason for error(s) 
 
(Choose from:  
- No maximum dose 
- Omission or abbreviation of drug frequency 
- Omission or abbreviation of drug route 
- No drug indication 
- Other) 
    Example 
  
    Patient 1 
 
 
                 3 
 
 
            2 
 
 
         Paracetamol 
            Codeine 
              
 
 
No maximum dose, no drug indication 
Abbreviation of drug route 
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IV  Intravenous 
SCut Subcutaneous 





Oral  Oral 
NKA No Known Allergies 
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                                                                   SUPPLEMENTARY MATERIAL 3: POSTER INTERVENTION WITH HIGHLIGHTED ERROR DOMAINS 
 
 
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open Qual
 doi: 10.1136/bmjoq-2020-001277:e001277. 10 2021;BMJ Open Qual, et al. Ross SL
SUPPLEMENTARY MATERIAL 4: INTERVIEW TOPIC GUIDE FOR DOCTORS 
Q1. Tell me about yourself. 
- What is your current role?  
- How long have you had this role?  
Q2. Can you talk me through a typical day in your role?  
- Talk me through your day yesterday.  
Q3. How much of your day do you spend prescribing?  
- What about the amount of time you spend looking at prescriptions?  
- Do you feel you have enough time in your day to do this properly?  
- How important would you say prescribing is in relation to all the other tasks you have to do?   
Q4. Can you describe how you fill in a Kardex for a newly admitted patient?  
- How would you then go about prescribing an as-required medication such as codeine to a patient on the ward?  
Q5. How confident are you with regards to prescribing as-required medication?  
- What do you think you do well with?  
- What part of this do you find most difficult and why?  
- What are your thoughts on the use of abbreviations when writing prescriptions? 
- If you weren’t sure about a prescription, what would you do?  
Q7. Have you noticed anything that makes prescribing difficult in your ward?  
- How often would you say you are interrupted when prescribing?  
- How would you describe the ward environment you work in?  
Q8. What are your thoughts on the current Kardex form used for prescriptions in your ward?  
- Does it facilitate prescription writing in any way?  
- Does it impede prescription writing in any way?  
- Is there anything you think needs improvement?  
- Do you think some documentation errors on the Kardex are more serious than others?  
Q9. What do you think would make prescribing as-required medication easier for you? 
- How easily do you think these ideas could be implemented in your ward environment?  
Q10. Do you have anything further to add? 
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SUPPLEMENTARY MATERIAL 5: INTERVIEW TOPIC GUIDE FOR NURSES 
Q1. What is your current role?  
- How long have you had this role?  
- Who are the main team members that you work with? 
Q2. Can you talk me through a typical day in your role? 
Q3. How much of your day do you spend administering medication to patients?  
- When in the day do you do this? 
- How much time do you spend looking at prescriptions on the drug Kardex?  
- Do you feel you have enough time in your day to do this properly?  
- How important would you say administering medication is in relation to all the other tasks you have to do?   
Q4. Can you describe the process you take when giving a drug to a patient from when the doctor writes on the Kardex? 
Q5. How confident are you with administering as-required drugs such as paracetamol? 
- What do you think you do well?  
- What part of this do you find most difficult and why? 
- What are your thoughts on doctors’ uses of abbreviations on the drug Kardex in terms of patient safety?  
- If you weren’t sure about a prescription, what would you do?  
Q7. Is there anything that makes prescribing difficult in your ward?  
- How would you describe the ward environment you work in?  
Q8. What are your thoughts on the current Kardex form used for prescriptions in your ward?  
- Does it make it easy to administer medication?  
- Does it impede this in any way?  
- Is there anything you think needs improvement?  
 
Q9. What do you think would reviewing as-required Kardex prescriptions easier for you?  
- How easily do you think these ideas could be implemented in your ward environment?  
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COM-B Component Elements Relevant Barrier Behaviour 
Physical capability Physical strength, skill or 
stamina 
None 
Psychological capability Knowledge or psychological 
strength, skill or stamina 




Opportunity afforded by the 
environment- time, locations, 
resources 
- Lack of visual prescribing 
guidance or cues on the 
ward  
- Rotational element of 
FY1s’ jobs 
- Lack of clear guidance on 
Kardexes 
Social opportunity Opportunity afforded by social 
factors- cultural norms, social 
cues 
Following by example 
Reflective motivation Reflective brain processes – 
plans and evaluations 
None 
Automatic motivation Automatic brain processes – 
desires, impulses, inhibitions 
Following by example  
Suggested tools 
for improvement 
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SUPPLEMENTARY MATERIAL 9: THEMES FROM QUALITATIVE ANALYSIS OF INTERVIEWS 
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SUPPLEMENTARY MATERIAL 10: TABLE SUMMARISING PERCENTAGE DECREASE IN NUMBER OF ERRORS PER PRESCRIPTION 
Week Percentage of 
patients with a 
‘route’ error on 
their Kardex (%) 
Percentage of 
patients with a 
‘frequency’ error 
on their Kardex 
(%) 
Percentage of patients 
with no maximum 
dose written (%) 
Pre Int 2 100 100 No data 
Pre Int 3 71.4 85.7 No data 
Pre Int 4 50 50 100 
Pre Int 5 83.3 83.3 83.3 
Pre Int 6 25 87.5 87.5 
Pre Int 7 100 100 66.7 
Post Int 1 25 62.5 50 
    Post Int 2 100 100 50 
    Post Int 3 80 100 20 
    Post Int 4 100 100 0 
    Post Int 5 66.7 83.3 0 
Post Int 6 80 40 40 
Post Int 7 54.4 54.4 27 
Post Int 8 50 75 25 
    








73.35 79.15 22.5 
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